Abiopharma

🔍 Ueda Tatsuro (Executive)

Company: TOYOTA MOTOR CORP/ (TM)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 110 shares of Common Stock at $16.71 per share (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 32,064.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 493 shares of Common Stock at $16.71 per share (Direct)
  Date: 2026-06-25 | Code: J | equity_swap_involved: 0 | shares_owned_after: 32,557.00 | transaction_form_type: 4 | Footnotes: F3, F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | shares_owned_after: 21,000.00

Footnotes:

• F1: The purchase was made in Japanese Yen and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 25, 2026 (at Japanese Yen 1.00 = U.S. dollar .00618).
• F2: These shares are held in trust for the benefit of the Reporting Person under a share-based compensation program.
• F3: These shares were acquired through the automatic reinvestment of dividends under the share-based compensation program.